Sinopharm eyes new $200m offshore borrowing

By John Loh
03 Sep 2018

Sinopharm Holding China Finance Leasing, a unit of state-owned China National Pharmaceutical Group, is tapping offshore banks for a $200m term loan.

Mandated lead arranger and bookrunner ANZ opened the fundraising into general syndication on August 24, and followed it up with bank presentations in Hong Kong last Friday.

The loan has a three year maturity from the date of agreement and a 2.675 year average life. Pricing is based ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial